semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Ventilator-Associated Pneumonia The patients were eligible for the study if they met the following 1. older than 18 years 2. clinical suspicion of VAP, defined by a new and persistent infiltrate on chest radiography associated with at least one of the following-purulent tracheal secretions, temperature of 38.3 celsius or higher, or a leukocyte count higher than 10000  Patients were excluded from the study if they were pregnant or in circulatory shock (which was defined as a systolic blood pressure of 90 mmHg and poor tissue perfusion) or had documented hypersensitivity to meropenem or an estimated creatinine clearance(determined by the Cockcroft-Gault method) of 60 ml/min
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Pneumonia Aspiration or more natural teeth no removable dentures no or mild cognitive impairments  less than 10 natural teeth removable dentures severe cognitive impairments
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Diarrhoea Predominant Irritable Bowel Syndrome Patient is at least 18 years of age at the initiation of EnteraGam therapy Patient has been previously diagnosed with IBS-D by the physician and has undergone at least one course of SOC treatment prior to receiving EnteraGam Patient has completed a minimum of eight weeks of EnteraGam therapy for his / her IBS-D There is recorded information regarding patient response to SOC or EnteraGam for stool frequency/consistency and abdominal pain  Patient has not taken EnteraGam for a minimum of eight weeks or has not used the product according to the directions provided by the prescribing physician Patient has not consented to the use of their clinical data in this retrospective clinical investigation
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Fidaxomicin Vancomycin Informed consent obtained and signed Age > 18 If female, participant must not be pregnant or nursing Negative pregnancy test required for females <61 years of age or without prior hysterectomy Confirmed current diagnosis of CDI, determined by having >3 loose or semi-formed stools for participants over 24 hours AND Positive stool assay for C. difficile EIA positive for toxin A/B; or Cytotoxin assay; or Nucleic Acid Amplification Test (NAAT, PCR or LAMP) based detection of toxigenic C. difficile  Inability to provide informed consent Inability to take oral capsules Receipt of >72 hours of antibiotics considered effective in the treatment of CDI, including metronidazole vancomycin fidaxomicin nitazoxanide rifaximin Prior infusion of bezlotoxumab within the previous 6 months Known presence of fulminant CDI, including hypotension, severe ileus or GI obstruction or incipient toxic megacolon
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Leukemia, Myeloid, Acute Histological confirmation of relapsed or refractory AML after prior anti-leukemic therapy by WHO classification Ineligible for cytotoxic therapy defined by the following: a. Age (>/=) 75 years or b. age 18 years with at least one of the following comorbidities: i. Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 or 3 ii. Cardiac history of congestive heart failure requiring treatment or ejection fraction (</=) 50% or chronic stable angina iii. Diffusing capacity of the lungs for carbon monoxide (</=) 65% or forced expiratory volume in the first second of expiration (</=) 65% iv. Creatinine clearance (>/=) 30 mL/min to< 45 mL/min v. any other comorbidity that the physician judges to be incompatible with intensive chemotherapy must be reviewed and approved by the Medical Monitor before screening and study enrollment Life expectancy of at least 12 weeks Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 Adequate liver and renal function  Patients with acute promyelocytic leukemia (French-American-British [FAB] class M3 AML) Known active central nervous system (CNS) involvement with AML at study entry ECOG Performance Status (>/=) 3 in patients who are (>/=) 75 years old or ECOG Performance Status of 4, regardless of age Prior exposure to Bcl-2 inhibitors, murine double minute 2 (MDM2) antagonists or prior exposure to experimental treatment targeting Raf, mitogen-activated protein kinase (MEK), or the mitogen-activated protein kinase (MAPK) RAS/RAF/MEK/ERK MAPK pathway Positive for hepatitis C virus (HCV), hepatitis B surface antigen (HBsAg) and known history of HIV, malignancy, active infection and cardiovascular diseases (CVs) Received strong cytochrome (CYP) 3A inhibitors, moderate CYP3A inhibitors, strong CYP3A inducers and moderate CYP3A inducers within 7 days prior to initiation of study treatment History of symptomatic Clostridium difficile infection within 1 month prior to dosing Additional arm specific Dose Escalation Arm A (Venetoclax and Cobimetinib) History or evidence of retinal pathology on ophthalmologic examination that is considered a risk factor for neurosensory retinal detachment/central serous chorioretinopathy (CSCR), retinal vein occlusion (RVO), or neovascular macular degeneration Left ventricular ejection fraction (LVEF) below institutional lower limit of normal (LLN) or below 50%, whichever is lower Arm B (Venetoclax and Idasanutlin)
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-99.0,  Clostridium Infections Patients with Clostridium difficile associated diarrhea  Patients < 18 years old
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Aspiration Pneumonia Males and females 18 years or older Patient has already been admitted to ICU Patient requires enteral feeding Patients receiving PPI therapy Informed consent by independent physician and next of kin ICU ventilated patients  Patients with anomalies or diseases of the nose, throat, or esophagus and or stomach Patients with known sensitivities or allergies to any of the feeding tube materials Inability to place patient is semi-Fowler's position Any clinically significant abnormality upon physical examination which may, in the opinion of the investigator, pose difficulty in inserting the feeding tube (e.g. cervical spine disorder) Pregnancy Recent abdominal surgery (less than 30 days)
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Anaesthesia, General Anesthesia, Intravenous Ventilation Adult, >18 years old 2. ENT-surgery where apnea is of benefit for the surgeon (eg. intraoral or laryngeal surgery) and the anesthesia time is <40 mins. 3. Capable of understanding the study information and sign the written consent  ASA>2 2. NYHA >2 3. BMI >30 4. Pregnancy 5. Manifest cardiac failure or coronary disease 6. Neuromuscular disease
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  Clostridium Difficile Infection Diarrhea Patients who have Been admitted to the medical unit on 7 West at St. Luke's Hospital (Duluth, MN) Been prescribed a systemic antibiotic of any kind (administered by oral or parenteral route), but have not yet started the regimen Consented to be randomized and take part in the study and are adults greater than 19 years of age  Patients who are/have Tube feeding Undergoing dialysis and other renal treatment An existing C. difficile infection A recent history of C. difficile infection (within the last 3 months) A recent history of antibiotic use (within the last 3 months) Inflammatory bowel disease, Crohn's disease, or other chronic gastrointestinal syndrome A history of acquired of genetic immunodeficiencies; active, acute or chronic serious infections (i.e., viral hepatitis, HIV/AIDS), or autoimmune disorders Undergoing gastrointestinal surgery, radiation, or cytotoxic chemotherapy Allergy to milk protein
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cancer of the Lung Lung Cancer Lung Neoplasms Adenocarcinoma of the Lung Non Small Cell Carcinoma of the Lung Small Cell Carcinoma of the Lung years of age or older, not previously diagnosed with cancer (except for basal cell carcinomas of the skin or a diagnosis of cancer within a month of surgery and for which the surgical procedure is being performed)  Prior history of cancer
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-99.0,  Clostridium Difficile Infection Relapse of Clostridium difficile infection with previous trial of vancomycin or fidaxomicin  Pregnancy or breastfeeding 2. Does not speak or understand the Danish language 3. Current antibiotic treatment other than metronidazole, vancomycin, fidaxomicin 4. fulminant colitis which contraindicates medical treatment 5. physician's evaluation that the patient cannot tolerate project
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 20.0-99.0,  Infection Inpatient with infectious disease and under broad-spectrum antibiotics  Poor prognosis was diagnosed or received conservative therapy only
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Ulcerative Colitis Age >18 years old Diagnosis of Ulcerative Colitis Acute Severe Colitis according to the Truelove and Witt's Steroid refractory according to the Oxford  Participant unable to consent for themselves Indication for immediate surgery (acute abdomen, perforation of the bowel, haemorrhage) Crohn's disease Participants with enteric infection confirmed on stool microscopy, culture or toxin Haemodynamic instability (mean arterial pressure <60) and not responsive to fluids Participants with clinically significant Cytomegalovirus infection (positive bodies, immunohistochemistry and signs of viraemia such as fever and abnormal liver function tests) Participants who are pregnant or currently breast-feeding Participants with current malignancy, excluding basal cell carcinoma Participants with flat low or high grade colonic dysplasia; sporadic adenomas permitted Participants with serious co-morbidities including: Immunodeficiency; Myocardial infarction or acute stroke within the last 3 months; Moderate or severe heart failure (New York Heart Association class III or IV); Active or suspected tuberculosis; Renal failure; Hepatic failure; other severe infections
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 2.0-65.0,  Undifferentiated Febrile Illness Fever of ≥ 38.0°C and for ≥4 days without a focus of infection ≥ 2 years and <65 years of age Able to take tablets orally Patient residing in Kathmandu Valley Able to come for follow up Can be reached by telephone/mobile phone 24 hours a day Written informed consent to participate in the study including assent for minors in addition to parental consent  Fever >14 days Pregnancy Obtundation Shock Visible jaundice Presence of signs of gastrointestinal bleeding History of hypersensitivity to either of the trial drugs Patient requiring intravenous antibiotic or hospital admission for any reason Contraindication of drug for any reason (e.g. drug interactions) Any patient fulfilling but already on antimicrobials and responding clinically to the treatment
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Surgical Site Infection Wound Infection Postoperative Pain Local Anesthetics Patients who are planned to a elective gastrointestinal surgery Biliary-pancreatic open procedures: biliodigestive Derivation, Pancreatoduodenectomy, Pancreato-jejunostomy (Puestow procedure, Frey) Open upper gastrointestinal procedures: total gastrectomy, subtotal gastrectomy (distal gastrectomy with Billroth I reconstruction or Billroth II or Roux-Y), Gastro-jejunum anastomosis, Open gastro-jejunal Roux Y bypass, intestinal resection, intestinal reconnection, intestinal Fistulectomy Open colorectal procedures: Right or Left Hemicolectomy, total colectomy, low anterior resection, abdominal-perineal resection Patients who decide signing the informed consent after explained the study Patients with postoperative follow-up of at least 30 days, in whom the wound and / or local complications will be evaluated  Patients operated laparoscopically Patients operated at another hospital Patients with clean surgical wounds Patients in whom an epidural or subarachnoid block is used Patients who are unable to sign the informed consent Patients with less than 50 kg Patients wiht history of: Malignant hyperthermia, cardiac disease (Heart failure, history of myocardial infarction, arrhythmias), Epilepsy, Allergic to amides Patients with incomplete follow-up (less than 30 days) Pregnant patients
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Respiratory Tract Infections Pneumonia, Bacterial Heart Failure DAHF diagnosis and suspected pulmonary infection BNP ≥ 500 pg/mL or NTproBNP ≥ 450 pg/mL for patients until 50 years old BNP ≥ 500 pg/mL or NTproBNP ≥ 900 pg/mL for patients with 51 years old BNP ≥ 500 pg/mL or NTproBNP ≥ 1800 pg/mL for patients older than 75 years  Antibiotic use (oral or endovenous) in the last 15 days Acute coronary syndrome Creatinine > 3,0 mg/dL or hemodialysis Pregnancy Second suspectec infection Suspected pulmonary thromboembolism cancer myocarditis
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile life expectancy > 3 months, 3 or more unformed stools in 24 hours prior to randomization, positive stool test within 72 hours of randomization  pregnancy, previous stool test positive within 12 months, toxic megacolon or ileus, already received >4 doses of treatment for current episode, inflammatory bowel disease, gastrointestinal surgery within 90 days of randomization (except appendectomy or cholecystectomy), documented aspiration of gastric contents within 90 days of randomization, requirement for treatment with oral probiotics, opiates, loperamide or diphenoxylate during the study duration, anticipated use of antibiotics for any reason during the study duration, known non-CDAD concurrent gastrointestinal infection, concurrent enrollment in another clinical trial for any reason, intolerance or hypersensitivity to Vancomycin, anaphylactic reaction to any food, current induction chemotherapy, HIV infection with Cluster of Differentiation 4 (CD4) count <200, or any medical or non-medical condition considered by the investigator to preclude participation